Methods of using and compositions comprising immunomodulatory compounds for the treatment and management of pulmonary hypertension

Details for Australian Patent Application No. 2005237490 (hide)

Owner Celgene Corporation

Inventors Zeldis, Jerome B.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2005237490

PCT Pub. Number WO2005/105088

Priority 60/565,172 23.04.04 US

Filing date 21 April 2005

Wipo publication date 10 November 2005

International Classifications

A61K 31/366 (2006.01) - having six-membered rings, e.g. delta-lactones

A61K 31/454 (2006.01)

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61K 31/554 (2006.01) - having at least one nitrogen and at least one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem

A61K 31/704 (2006.01)

Event Publications

16 November 2006 PCT application entered the National Phase

  PCT publication WO2005/105088 Priority application(s): WO2005/105088

29 January 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005237491-Sternal reconstruction system

2005237489-Inhibition of biogenic sulfide production via biocide and metabolic inhibitor combination